Tau PET imaging in patients with schizophrenia and patients with frontotemporal dementia

Tau PET imaging in patients with schizophrenia and patients with frontotemporal dementia - Tau imaging in patients with schizophrenia and patients with frontotemporal dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026385

Enrollment

Registered

2017-03-27

Start date

2017-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia, frontotemporal dementia

Interventions

healthy controls patients with schizophrenia spectrum and other psychotic disorders patients with frontotemporal dementia (FTD/FTLD)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants who can understand the content of this study. Each patient must meet the diagnostic criterion.

Exclusion criteria

Exclusion criteria: Subjects with severe physical, or other psychiatric diseases Subjects with strong suicide ideation Subjects during (probable) pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
Distribution of Tau in the brain	—

Countries

Japan

Contacts

Public ContactKazuko Suzuki

National Institutes for Quantum Science and Technology Clinical Research Section

suzuki.kazuko@qst.go.jp+81-43-206-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026